Nurix Therapeutics is a clinical-stage biopharmaceutical company focused on targeted protein degradation, seeking a Vice President, Translational Medicine & Clinical Biomarkers to own the strategy across Nurix’s oncology and immunology pipeline, from early target engagement through late-stage development.
Reporting to the CSO, the VP will lead a high-performing team, partner with Research, Clinical Development, Regulatory Affairs and Data Science, and represent Nurix externally as a scientific
#J-18808-LjbffrVP Translational Medicine & Biomarker Strategy in brisbane at Unknown Company
This position is listed as full time and onsite.